Stocks to Watch, Dec 16: Tata Power, SBI, Britannia, Delhivery, HCLTech, Newgen Software, Zydus Life, Ion Exchange, KIMS

Speaking at the launch of a new version of its Yono app, bank chairman C S Setty said the bank has begun an initiative in which dedicated executives or floor managers help customers migrate to the digital channel, which is also very convenient for them.

"We already have 3,500 executives in branches to help the customers and will take it to 10,000 by March 31, 2026," Setty told reporters in Mumbai.

Setty said a subsidiary company is taking care of the project and undertaking the fresh hiring of staff for the purpose, Setty said.

Besides, the government on Monday appointed Ravi Ranjan as the new Managing Director of State Bank of India (SBI).

As per an investor presentation, 65% of the capex is aimed at clean energy projects.

Tata Power, which made a capital expenditure (capex) of ₹17,273 crore in FY25, almost doubled the same to ₹25,000 crore in FY26.

The total capex estimated between FY26 and FY30 is ₹1.25 lakh crore, with ₹25,000 crore spent annually, as per the presentation.

360 One: 360 One Asset on Monday said it has raised a ₹2,300 crore real estate fund in four months.

The majority of the amount raised through the Category II Alternative Investment Fund (AIF) has already been deployed in projects, as per a statement.

The balance sum will be deployed in the coming months, it added.

The AIF will aim to capture opportunities across infrastructure and income-generating commercial real assets, targeting a blend of stable yields and long-term capital appreciation, the statement said.

"Varanasi, one of the world's oldest living cities, continues to draw seekers from across the globe for its spiritual significance. The opening of Avantika by the Ganges – IHCL SeleQtions adds a dimension to our brandscape, offering guests a sanctuary that blends timeless traditions with contemporary comforts," IHCL Executive Vice President of New Businesses and Hotel Openings Deepika Rao said in a statement.

The ordinary resolution seeking approval of Garg's appointment was approved by shareholders in a postal ballot through remote e-voting with 99.75% of votes polled in favour, Hyundai Motor India Ltd (HMIL) said in a regulatory filing.

In October this year, the HMIL board had approved the elevation of its Chief Operating Officer, Garg, to Managing Director and CEO from January 1, 2026, as part of its succession planning.

Stamp duty, registration fee, and incidental charges are to be borne by the National Bank for Agriculture and Rural Development (NABARD), while all dues prior to transfer and the NLMC (National Land Monetisation Corporation) fee as per the letter of undertaking dated June 29, 2025, will be borne by MTNL.

MTNL's residential property block has a plot area of 2,680 sqm and a built-up area of 4,019.02 sqm.

The expanded partnership establishes HCLTech as Aurobay Technologies’ trusted partner for managing and optimising SAP, Siemens Teamcenter PLM software and integration services in Sweden and China.

This will unlock cost efficiency, operational resilience and digital innovation across Aurobay’s manufacturing and engineering functions by leveraging HCLTech’s flagship service transformation platform, AI Force.

The service offers pickups within 15 minutes of booking on its app, the company said in a regulatory filing dated December 15.

The resubmission has been accepted as a Class I response, and as a result, the company has received January 14, 2026, as the new PDUFA date.

These institutions collectively manage over $13 billion in assets under administration and serve more than 373,000 members. Members will gain access to secure, seamless and frictionless digital banking experiences that enhance engagement and personalisation.

It has also approved the incorporation of a new wholly owned subsidiary (“WOS”) of the company, in the name and style “RPG Active Pharma Limited” or such other name as may be approved by the Ministry of Corporate Affairs, to be engaged, inter alia, in the business of manufacture and marketing of active pharmaceutical ingredients (“API”) and related pharmaceutical products.